Counselling Framework for Germline <i>BRCA1/2</i> and <i>PALB2</i> Carriers Considering Risk-Reducing Mastectomy
Female <i>BRCA1/2</i> and <i>PALB2</i> germline pathogenic variant carriers have an increased lifetime risk of breast cancer and may wish to consider risk-reducing mastectomy (RRM) for surgical prevention. Quantifying the residual lifetime risk and absolute benefit from RRM requires careful consider...
שמור ב:
| Principais autores: | , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
MDPI AG
2024-01-01
|
| סדרה: | Current Oncology |
| נושאים: | |
| גישה מקוונת: | https://www.mdpi.com/1718-7729/31/1/23 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
